콘텐츠로 건너뛰기
주식/증권 📈 긍정적

Here's Why You Should Retain McKesson Stock in Your Portfolio for Now

Yahoo Finance 2026/07/02 18:11:00 1회
요약

McKesson's growth in specialty pharma, oncology services and tech-driven solutions is boosting earnings, but policy and execution risks remain in focus.

원문 기사 보기
관련 뉴스
Apple Intelligence gets China nod; to use Alibaba AI models
2026/07/15
Luxury stocks rally on Richemont sales beat — but the sector still needs China, says analyst
2026/07/15
As Q2 earnings kick off, these financial stocks earn an A+ for profitability
2026/07/15
Jacobs wins three U.K. National Highways contracts
2026/07/15
뉴스 목록으로